Skip to main content

Table 5 Multivariate analysis by the Cox proportional hazard regression model for OS in GBM patients from tumor banks

From: Identification of prognostic values defined by copy number variation, mRNA and protein expression of LANCL2 and EGFR in glioblastoma patients

Variable HR (95% CI) P
Age (years)   
 ≥ 60 vs < 60 NA 0.117
LANCL2 gene status   
 Amplification vs no alteration 2.319 (1.306–4.115) 0.004
EGFR gene status   
 Amplification vs no alteration NA 0.605
LANCL2 and EGFR genes status   
 Co-amplification vs no alteration NA 0.656
  1. HR hazard ratio, CI confidence interval, NA not applicable